These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27893710)

  • 1. MUC1-C activates BMI1 in human cancer cells.
    Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
    Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma.
    Tagde A; Markert T; Rajabi H; Hiraki M; Alam M; Bouillez A; Avigan D; Anderson K; Kufe D
    Oncotarget; 2017 Sep; 8(41):69237-69249. PubMed ID: 29050200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells.
    Rajabi H; Hiraki M; Kufe D
    Oncogene; 2018 Apr; 37(16):2079-2088. PubMed ID: 29379165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
    Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
    Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
    Dimri M; Kang M; Dimri GP
    Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.
    Rajabi H; Alam M; Takahashi H; Kharbanda A; Guha M; Ahmad R; Kufe D
    Oncogene; 2014 Mar; 33(13):1680-9. PubMed ID: 23584475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC1-C activates EZH2 expression and function in human cancer cells.
    Rajabi H; Hiraki M; Tagde A; Alam M; Bouillez A; Christensen CL; Samur M; Wong KK; Kufe D
    Sci Rep; 2017 Aug; 7(1):7481. PubMed ID: 28785086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma.
    Wang HB; Liu GH; Zhang H; Xing S; Hu LJ; Zhao WF; Xie B; Li MZ; Zeng BH; Li Y; Zeng MS
    FEBS J; 2013 Jun; 280(12):2929-44. PubMed ID: 23601184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
    Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus.
    Liu Y; Liu F; Yu H; Zhao X; Sashida G; Deblasio A; Harr M; She QB; Chen Z; Lin HK; Di Giandomenico S; Elf SE; Yang Y; Miyata Y; Huang G; Menendez S; Mellinghoff IK; Rosen N; Pandolfi PP; Hedvat CV; Nimer SD
    Sci Signal; 2012 Oct; 5(247):ra77. PubMed ID: 23092893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
    Yasumizu Y; Rajabi H; Jin C; Hata T; Pitroda S; Long MD; Hagiwara M; Li W; Hu Q; Liu S; Yamashita N; Fushimi A; Kui L; Samur M; Yamamoto M; Zhang Y; Zhang N; Hong D; Maeda T; Kosaka T; Wong KK; Oya M; Kufe D
    Nat Commun; 2020 Jan; 11(1):338. PubMed ID: 31953400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC1-C drives MYC in multiple myeloma.
    Tagde A; Rajabi H; Bouillez A; Alam M; Gali R; Bailey S; Tai YT; Hideshima T; Anderson K; Avigan D; Kufe D
    Blood; 2016 May; 127(21):2587-97. PubMed ID: 26907633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
    Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
    Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells.
    Hata T; Rajabi H; Takahashi H; Yasumizu Y; Li W; Jin C; Long MD; Hu Q; Liu S; Fushimi A; Yamashita N; Kui L; Hong D; Yamamoto M; Miyo M; Hiraki M; Maeda T; Suzuki Y; Samur MK; Kufe D
    Cancer Res; 2019 Nov; 79(22):5711-5722. PubMed ID: 31519689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.
    Alam M; Rajabi H; Ahmad R; Jin C; Kufe D
    Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.
    Calao M; Sekyere EO; Cui HJ; Cheung BB; Thomas WD; Keating J; Chen JB; Raif A; Jankowski K; Davies NP; Bekkum MV; Chen B; Tan O; Ellis T; Norris MD; Haber M; Kim ES; Shohet JM; Trahair TN; Liu T; Wainwright BJ; Ding HF; Marshall GM
    Oncogene; 2013 Aug; 32(31):3616-26. PubMed ID: 22907436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer.
    Hata T; Rajabi H; Yamamoto M; Jin C; Ahmad R; Zhang Y; Kui L; Li W; Yasumizu Y; Hong D; Miyo M; Hiraki M; Maeda T; Suzuki Y; Takahashi H; Samur M; Kufe D
    Mol Cancer Ther; 2019 Oct; 18(10):1744-1754. PubMed ID: 31308076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.
    Rajabi H; Ahmad R; Jin C; Kosugi M; Alam M; Joshi MD; Kufe D
    J Biol Chem; 2012 Mar; 287(13):10703-10713. PubMed ID: 22318732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway.
    Alam M; Bouillez A; Tagde A; Ahmad R; Rajabi H; Maeda T; Hiraki M; Suzuki Y; Kufe D
    Mol Cancer Res; 2016 Dec; 14(12):1266-1276. PubMed ID: 27658423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism.
    Bednar F; Schofield HK; Collins MA; Yan W; Zhang Y; Shyam N; Eberle JA; Almada LL; Olive KP; Bardeesy N; Fernandez-Zapico ME; Nakada D; Simeone DM; Morrison SJ; Pasca di Magliano M
    Carcinogenesis; 2015 Jul; 36(7):730-8. PubMed ID: 25939753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.